IP Verse

Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione

Patent No. EP3042659 (titled "Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione") was filed by Celgene on Sep 3, 2004. The application was issued on Dec 19, 2018.

Patent Summary

The present disclosure generally relates to data communication networks, and more particularly to a method and system for managing network service level agreements in an intelligent networking environment. Modern networked computer environments are evolving to provide service level agreements (SLAs) for network resources and services to customers. A service level agreement (SLA) is a service contract between a service provider and a customer, which describes the type, level, and expected performance of services provided by the service provider. SLAs are typically negotiated between a customer and a service provider to address various service requirements, such as performance, support, reliability, security, availability, or capacity. SLAs may be used to provide differentiated services, such as a guaranteed bandwidth, a guaranteed throughput, or a guaranteed quality of service (QoS), to a network customer. SLAs are typically applied to a network service as a whole, for example, a network connection, such

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BACHELINAug 7, 2019HOFFMANN EITLE
GENERICS UKAug 7, 2019ELKINGTON AND FIFE
HAMM & WITTKOPPAug 7, 2019HAMM & WITTKOPP
HOFFMANN EITLEJul 25, 2019HOFFMANN EITLE
PRUSSJul 25, 2019HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3042659

CELGENE
Application Number
EP15199521A
Filing Date
Sep 3, 2004
Status
Revoked
Jul 3, 2020
Publication Date
Dec 19, 2018
External Links
Slate, Register , Google Patents